Published Research

Call +1 (855) 645-2583International: +1 (866) 663-3102

Archives

BHI THERAPEUTIC SCIENCES ABSTRACT TO BE PRESENTED AT GERMAN STEM CELL CONFERENCE

August 29th, 2019 (No Comments)

BHI Therapeutic Sciences (BHITS) has been invited to present its abstract, “A retrospective chart review study of allogeneic umbilical cord blood mononuclear cell therapy for stroke,” at the German Stem Cell Network;s 7th Annual GSCN Conference being held Sept. 23-25 at the Max Delbruck Center for Molecular Medicine in Berlin.  Marina Manvelyan, PhD., BHITS Clinical Research Scientist said: “We are […]

BHI Therapeutic Sciences studies are registered at the clinical trial registries

August 29th, 2019 (No Comments)

Clinical trials are research investigations that play an important role in the development of health information and research for public health care. Clinical trials guiding principles are based on maximum benefit and minimal risk to the participants enrolled in a study. According to the Ethical Principles for Medical Research Involving Human Subjects (World Medical Association […]

BHI Therapeutic Sciences exhibits at World Congress on Anti-Aging Medicine in Las Vegas

January 15th, 2019 (No Comments)

BHI Therapeutic Sciences (BHITS), BHI Rejuve, and Alpha Blu Skin Care participated in the 26th World Congress on Anti-Aging Medicine & Exhibition in Las Vegas, December 13-15, 2018. Prominent, influential, and notable leaders in healthcare delivered keynote presentations at the 26th Annual World Congress: all of which were focused on the critical need for both innovation […]

What do Athletes Need to Know about Stem Cell Therapies?

September 24th, 2018 (No Comments)

·        Osteoarthritis (OA) is the most common form of arthritis and a major cause of pain and disability in adult individuals. Systemic inflammation observed in OA is partially reflective of local synovial inflammation. Common treatments for OA include agents for control of pain and inflammation, such as non-steroidal anti-inflammatory drugs, analgesics including opioids, locally administered corticosteroids […]

BHI Therapeutic Sciences Inc. Notified by FDA that it can proceed with New Drug Clinical Trial for Acute Ischemic Stroke

June 5th, 2018 (No Comments)

BHI Therapeutic Sciences (BHITS), a leader in stem cell therapy and research utilizing human umbilical cord blood, announced today that the company has been notified by the Food and Drug Administration (FDA) that its Investigational New Drug (IND) application to allow for the initiation of a clinical study of an FDA-approved cell therapy (HCP, cord […]

Professional Physique Champion is named Ambassador for BHI Slovakia.

June 5th, 2018 (No Comments)

Anton Antipov, an International Federation of Body Building and Fitness (IFBB) professional physique champion and fitness model, recently visited BHI Slovakia, stem cell research and treatment center, where he was named an ambassador for the healthcare organization. Mr. Antipov is an accomplished competitor and New York-based model, who has made a name for himself on […]

Stem Cells: The Next Frontier documentary screening for investors in NYC.

June 5th, 2018 (No Comments)

BHI Therapeutic Sciences (BHITS) and Brian Mehling, M.D. hosted a private screening of Stem Cells: The Next Frontier on Tuesday, February 13 in New York. The evening included a Q & A session and information on how to participate by becoming an investor to make these life-saving stem cells therapies more accessible to patients across […]

BHI Therapeutic Sciences attended the World Economic Forum in Davos, Switzerland.

June 5th, 2018 (No Comments)

The 2018 World Economic Forum (WEF) in Davos explored the ideas, innovations and discoveries that are reshaping our world by working closely with those in the vanguard of change from such fields as the arts, culture, engineering, media, medicine, science, and technology. During the past few days, the US-based company BHI Therapeutic Sciences (BHITS) represented […]

WORLD-RENOWNED STEM CELL RESEARCHER AND BOARD-CERTIFIED SURGEON, DR. BRIAN MEHLING, SET TO ATTEND THE 48TH ANNUAL WORLD ECONOMIC FORUM IN DAVOS

June 5th, 2018 (No Comments)

FOUNDER OF BLUE HORIZON INTERNATIONAL AVAILABLE TO DISCUSS BREAKTHROUGHS IN STEM CELL RESEARCH ZURICH, Switzerland – January 18, 2017 – Dr. Brian Mehling, world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, and founder of Blue Horizon International (BHI), will be attending The 48th Annual World Economic Forum (WEF) in DAVOS from January 23-26. This will […]